Establishing key performance indicators for inflammatory bowel disease in the UK

No Thumbnail Available
Authors
Quraishi, M. N.
Dobson, E.
Ainley, R.
Din, S.
Wakeman, R.
Cummings, F.
Sebastian, S.
Bloom, S.
Limdi, J. K.
Dhar, A.
Journal
Frontline gastroenterology
Type
Journal Article
Publisher
BMJ
Rights
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
BACKGROUND AND AIMS: Healthcare quality improvement (QI) is the systematic process to continuously improve the quality of care and outcomes for patients. The landmark Inflammatory Bowel Disease (IBD) UK National Audits provided a means to measure the variation in care, highlighting the need to define the standards of excellence in IBD care. Through a consensus approach, we aimed to establish key performance indicators (KPIs), providing reliable benchmarks for IBD care delivery in UK. METHODS: KPIs that measure critical aspects of a patient journey within an IBD service were identified though stakeholder meetings. A two-stage Delphi consensus was then conducted. The first involved a multidisciplinary team of IBD clinicians and patients to refine definitions and methodology. The second stage assessed feasibility and utility of the proposed QI process by surveying gastroenterology services across UK. RESULTS: First, the four proposed KPIs were refined and included time from primary care referral to diagnosis in secondary care, time to treatment recommendation following a diagnosis, appropriate use of steroids and advanced therapies prescreening and assessment. Second, the Delphi consensus reported >85% agreement on the feasibility of local adoption of the QI process and >75% agreement on the utility of benchmarking of the KPIs. CONCLUSIONS: Through a structured approach, we propose quantifiable KPIs for benchmarking to improve and reduce the individual variation in IBD care across the UK.
Citation
Quraishi MN, Dobson E, Ainley R, Din S, Wakeman R, Cummings F, et al. Establishing key performance indicators for inflammatory bowel disease in the UK. Frontline Gastroenterol. 2023;14(5):407-14.
Note
RD&E staff can access the full-text of this article by clicking on the 'Additional Link' above and logging in with NHS OpenAthens if prompted.